PARABOLIC DRUGS (India) Financial Indicators Patterns

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:4em;padding-top: 25px;;'>PA</div>
We recommend to use PARABOLIC DRUGS fundamental analysis to find out if markets are now mispricing the company. Put it differently this interface allows you to confirm available drivers of PARABOLIC DRUGS as well as the relationship between them. We found twenty-three available financial ratios for PARABOLIC DRUGS which can be compared to its competitors. To make sure the equity is not overpriced, please check all PARABOLIC DRUGS fundamentals including its Debt to Equity, Earnings Per Share and the relationship between Cash per Share and Book Value Per Share .

Chance of Financial Distress

PARABOLIC DRUGS has    50 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


Parabolic Drugs Limited develops, manufactures, and sells active pharmaceutical ingredients and API intermediates in India. Parabolic Drugs Limited was founded in 1996 and is based in Chandigarh, India. PARABOLIC DRUGS operates under Drug Manufacturers - Specialty Generic classification in India and is traded on National Stock Exchange of India. It employs 1011 people.
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
Business AddressSCO 186-187
IndustryDrug Manufacturers - Specialty & Generic
Phone91 17 2418 2800

PARABOLIC DRUGS Key Fundamentals


PARABOLIC DRUGS is considered to be number one stock in beta category among related companies. It is considered to be number one stock in ebitda category among related companies .

PARABOLIC DRUGS Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Your Equity Center. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Company logos by clearbit